top of page

Semaglutide is a long-acting GLP-1 receptor agonist developed as a synthetic analogue of the endogenous incretin hormone GLP-1. It is one of the most extensively studied GLP-1 receptor agonists in the research literature, with preclinical data supporting appetite suppression, slowed gastric emptying, and improved glycaemic regulation. It is studied for obesity, metabolic syndrome, and type 2 diabetes-related research applications.

Semaglutide

From $90.00Sale Price
Quantity
bottom of page